Kissei Pharmaceutical Co Ltd

Kissei Pharmaceutical Co Ltd

Health CarePharmaceuticals and Biotechnology
  • Price (JPY)2,555.00
  • Today's Change22.00 / 0.87%
  • Shares traded53.00k
  • 1 Year change+10.56%
  • Beta0.8883
Data delayed at least 20 minutes, as of Jan 31 2023 06:00 GMT.
More ▼
Take Action
Take Action
Add this security to watchlist, portfolio, or create an alert to track market movement

Profile data is unavailable for this security.

About the company

KISSEI PHARMACEUTICAL CO.,LTD. is a Japan-based company mainly engaged in the manufacture and sale of pharmaceutical products. The Company is engaged in the collection and analysis of medicine development information, and the manufacture and sale of medicines. It is also engaged in the purchase and sale of related materials, system development and information process work, construction contract work such as new construction, expansion and renovation of factories, laboratories and offices, the management of facility and equipment work, information collection and development support work, noodle manufacture and sale, and insurance agency business.

  • Revenue in JPY (TTM)65.86bn
  • Net income in JPY10.58bn
  • Incorporated1946
  • Employees1.83k
  • Location
    Kissei Pharmaceutical Co Ltd19-48, YoshinoMATSUMOTO-SHI 399-8710JapanJPN
  • Phone+81 263259081
  • Fax+81 263257899
  • Websitehttp://www.kissei.co.jp
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
(YOY change %)
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
(5 yr growth rate)
Eiken Chemical Co Ltd45.03bn6.54bn71.06bn745.009.301.2310.081.58175.57175.571,208.081,329.460.70612.793.3860,436,240.0010.268.2812.8010.8548.9845.3514.5411.042.43--0.057531.2711.205.2623.2816.3420.5115.33
TORII PHARMACEUTICAL CO., LTD.48.87bn3.99bn87.55bn560.0021.400.722319.711.79142.09142.091,739.264,209.040.37822.732.4187,258,930.003.096.823.377.8549.1451.068.1715.538.03--0.0016.7812.68-4.84-3.463.51-13.220.00
Shin Nippon Biomedical Laboratories Ltd20.14bn8.04bn96.92bn994.0012.053.8910.294.81193.21193.21483.67597.850.42991.626.7320,257,290.0017.215.0625.227.6553.5045.4840.0314.970.9142--0.423124.1317.460.577894.65--9.71--
TOWA PHARMACEUTICAL CO., LTD173.86bn9.36bn104.68bn4.08k10.890.72094.480.6021186.62186.623,473.482,818.590.57521.453.6842,633,890.003.105.904.337.8439.1044.125.3910.220.8056--0.51816.486.9214.2814.0123.34-8.5012.47
KYORIN Holdings, Inc.105.53bn5.05bn111.06bn2.22k19.490.789712.561.0588.1888.181,841.562,176.730.6211.303.0447,491,000.002.973.333.664.0346.1351.064.795.461.87--0.144370.592.56-1.77-35.86-11.650.338-2.16
Zeria Pharmaceutical Co Ltd64.64bn5.84bn113.94bn1.74k16.341.549.981.76131.27131.271,450.171,395.010.50091.463.7937,213,090.004.543.107.274.9871.6971.289.075.920.74556.650.466545.8712.84-1.7026.032.25-17.521.81
Kissei Pharmaceutical Co Ltd65.86bn10.58bn131.24bn1.83k11.040.58388.961.99229.45229.451,428.104,338.620.27181.753.0036,026,800.004.413.164.793.4248.5355.9816.2310.454.82--0.007934.12-5.31-1.83144.4810.83-5.394.01
Mochida Pharmaceutical Co Ltd109.37bn9.58bn138.35bn1.54k13.630.994311.311.26252.77252.772,899.753,464.880.6782.243.5870,835,500.005.945.227.126.4053.9951.578.757.763.62--0.0040.566.982.5123.084.3921.993.04
KAKEN PHARMACEUTICAL CO., LTD.75.27bn8.79bn172.50bn1.16k16.111.0115.282.29233.13233.131,994.153,730.820.45222.063.6564,660,650.005.2810.156.0312.0654.4356.0911.6818.285.04--0.026737.001.41-5.61-28.77-15.396.710.00
Sawai Group Holdings Co Ltd192.93bn-31.03bn174.73bn2.97k--0.8639--0.9057-709.06-709.064,400.234,618.620.49431.482.8865,002,360.00-11.391.25-15.971.7031.7638.97-23.052.461.24-155.680.258576.823.527.92-329.08--4.380.00
Data as of Jan 31 2023. Currency figures normalised to Kissei Pharmaceutical Co Ltd's reporting currency: Japanese Yen JPY

Institutional shareholders

10.58%Per cent of shares held by top holders
HolderShares% Held
Nomura Asset Management Co., Ltd.as of 30 Dec 2022913.30k1.76%
JPMorgan Asset Management (Japan) Ltd.as of 31 Dec 2022888.80k1.72%
The Vanguard Group, Inc.as of 05 Jan 2023849.96k1.64%
BlackRock Fund Advisorsas of 05 Jan 2023453.00k0.87%
Baillie Gifford & Co.as of 31 Oct 2022443.10k0.86%
Nikko Asset Management Co., Ltd.as of 06 Jan 2023427.00k0.82%
Daiwa Asset Management Co. Ltd.as of 30 Dec 2022419.80k0.81%
Dimensional Fund Advisors LPas of 31 Dec 2022410.51k0.79%
Norges Bank Investment Managementas of 31 Dec 2021347.40k0.67%
Brandes Investment Partners LPas of 26 Jan 2023327.70k0.63%
More ▼
Data from 31 Dec 2021 - 31 Dec 2022Source: FactSet Research Systems Inc.
An LSEG Business
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.